Back to search

Article

The partial erythropoietin receptor agonist ML1-R is a potent neuroprotective drug with a distinct signaling profile.

2025-01-08

Abstract excerpt

<title>Abstract</title> <p>Erythropoietin (EPO) is a glycoprotein that stimulates red blood cell production in the bone marrow and protects neurons from oxidative stress, making it a potential treatment for various neurological diseases. However, EPO analogs often lead to side effects like excessive erythropoiesis and tumor growth. In this study, we aimed to develop ML1-R, a peptide derived from the C-helix of EP...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
867c5b4a-ef55-5381-8002-01b5768a2d9d
DOI
10.21203/rs.3.rs-5779616/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The partial erythropoietin receptor agonist ML1-R is a potent neuroprotective drug with a distinct signaling profile.DOI 10.21203/rs.3.rs-5779616/v1
Select a neighboring publication to make it the new centre.